13F Holdings
中文EN

ELV Elevance Health, Inc.

Hospital & Medical Service Plans · NYSE · SEC CIK 1156039 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY3.6%
TTM net income YoY-7.1%
TTM EPS YoY-4.0%
Revenue 3-yr CAGR6.2%
Net income 3-yr CAGR-5.0%

Margins

Gross margin—
Operating margin2.7%
Net margin2.5%
FCF margin3.2%
EBITDA margin3.4%

Returns

ROE11.6%
ROA4.1%
ROIC (approx.)6.7%
Asset turnover1.61x

Leverage & solvency

Liabilities / assets65.0%
Debt / equity0.69x
Current ratio1.47x
Interest coverage3.76x

Cash quality & payout

Operating cash flow / net income1.48x
Accruals ratio-2.0%
Payout ratio29.2%
Capex / revenue0.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$199.12B$177.01B$171.34B$156.59B$138.64B
Cost of revenue$21.18B$19.75B$17.29B$13.04B$10.89B
SG&A expense$20.98B$20.02B$20.09B$17.70B$15.92B
Operating income$7.20B$7.86B$8.50B$8.28B$7.56B
Interest expense$1.40B$1.19B$1.03B$851.00M$798.00M
Pretax income$6.71B$7.90B$7.71B$7.60B$8.00B
Income tax$1.05B$1.93B$1.72B$1.71B$1.85B
Net income$5.66B$5.98B$5.99B$5.89B$6.16B
EBITDA$8.74B$9.26B$10.24B$9.96B$8.86B
EPS (basic)25.2825.8125.3824.5625.26
EPS (diluted)25.2125.6825.2224.2824.95
Dividends declared per share——5.925.124.52
Weighted avg. shares (diluted)224.60M232.90M237.40M242.80M246.80M
Balance sheet
Cash & equivalents$9.49B$8.29B$6.53B$7.39B$4.88B
Short-term investments$25.88B$25.20B$29.61B$25.95B$26.27B
Current assets$63.00B$58.94B$60.03B$55.62B$51.12B
PP&E, net$4.68B$4.65B$4.36B$4.32B$3.92B
Goodwill$28.34B$28.28B$25.32B$24.38B$24.23B
Intangibles$11.20B$12.09B$10.27B$10.31B$10.62B
Total assets$121.49B$116.89B$108.93B$102.75B$97.46B
Current liabilities$41.03B$40.58B$41.79B$39.70B$34.88B
Short-term debt$1.10B$1.65B$1.65B$1.50B$1.60B
Long-term debt$30.80B$29.22B$23.25B$22.35B$21.16B
Total debt$31.90B$30.87B$24.89B$23.85B$22.76B
Total liabilities$77.47B$75.46B$69.52B$66.42B$61.29B
Shareholders' equity$43.88B$41.31B$39.31B$36.24B$36.09B
Net debt$22.41B$22.58B$18.37B$16.46B$17.88B
Shares outstanding220.72M227.48M233.07M237.96M241.77M
Cash flow statement
Operating cash flow$4.29B$5.81B$8.06B$8.40B$8.36B
Capital expenditure$1.12B$1.26B$1.30B$1.15B$1.09B
Free cash flow$3.17B$4.55B$6.76B$7.25B$7.28B
Investing cash flow-$1.34B-$5.17B-$5.57B-$4.56B-$9.64B
Financing cash flow-$1.74B$1.19B-$3.35B-$1.32B$423.00M
Depreciation & amortization$1.55B$1.39B$1.75B$1.68B$1.30B
Stock-based compensation$276.00M$191.00M$289.00M$264.00M$255.00M
Dividends paid$1.53B$1.51B$1.40B$1.23B$1.10B
Share buybacks$2.60B$2.90B$2.68B$2.32B$1.90B

Free plan shows the latest 5 periods; Pro shows all 19 🔒

· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.